ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 85 filers reported holding ARGENX SE in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,839,679 | +395.9% | 3,742 | +253.7% | 0.05% | +100.0% |
| Q4 2021 | $371,000 | -51.1% | 1,058 | -58.0% | 0.02% | -64.1% |
| Q2 2021 | $758,000 | +102.1% | 2,518 | +7.8% | 0.06% | +190.9% |
| Q4 2019 | $375,000 | +4.2% | 2,336 | -8.2% | 0.02% | -31.2% |
| Q2 2019 | $360,000 | +73.9% | 2,546 | +17.9% | 0.03% | +146.2% |
| Q4 2018 | $207,000 | -7.2% | 2,159 | -38.8% | 0.01% | -45.8% |
| Q4 2017 | $223,000 | – | 3,530 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |